FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

22061000087108: ensemble de référence des noms commerciaux de vaccins (concept de métadonnées fondamentales)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2019. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
72391000087115 Administered tradename codes for vaccines reference set (foundation metadata concept) en Fully specified name Active Only initial character case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
72401000087117 Administered tradename codes for vaccines reference set en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
72411000087115 Vaccine administered tradename codes reference set en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
78571000087114 ensemble de référence des noms commerciaux de vaccins fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)
78581000087111 ensemble de référence des noms commerciaux de vaccins (concept de métadonnées fondamentales) fr Fully specified name Active Entire term case insensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)
72421000087111 This refset is intended to capture the product administered at the point of immunization and includes the vaccine tradenames that are currently licensed for use in Canada and those obtained through special access programs for use in Canada. en Definition Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)


146 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Administered tradename codes for vaccines reference set (foundation metadata concept) est un(e) (attribut) ensemble de référence simple canadien true Inferred relationship Some

Members
RABAVERT 2.5 international units per milliliter powder for solution for injection Bavarian Nordic A/S (real clinical drug)
RECOMBIVAX HB 10 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug)
RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug)
RECOMBIVAX HB 5 micrograms per 0.5 milliliter suspension for injection Merck Canada Inc. (real clinical drug)
Rota ROTARIX GSK
RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug)
RabAvert 2.5 international units per milliliter powder for solution for injection Novartis Vaccines and Diagnostics Gmbh (real clinical drug)
RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug)
Zos SHINGRIX GSK
SINOPHARM-BIBP COVID-19 whole inactivated virus vaccine (real medicinal product)
SINOPHARM-WIBP COVID-19 whole inactivated virus vaccine (real medicinal product)
SPIKEVAX Bivalent (Original / Omicron BA.1) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug)
SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug)
SPIKEVAX messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug)
SPIKEVAX messenger ribonucleic acid 0.20 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug)
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug)
Soberana 02 COVID-19 recombinant spike protein vaccine (real medicinal product)
SpikoGen COVID-19 recombinant spike protein vaccine (real medicinal product)
Sputnik Light COVID-19 non-replicating vector vaccine (real medicinal product)
COVID-19 Sputnik V
Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug)
DTaP-IPV TETRAVAC-ACELLULAIRE SP
TRIPACEL suspension for injection Sanofi Pasteur Limited (real clinical drug)
TYPHERIX 25 micrograms per 0.5 milliliter liquid for injection GlaxoSmithKline Inc. (real clinical drug)
Typh-I TYPHIM Vi SP
Td ADSORBED SP
Td Polio Adsorbed suspension for injection Sanofi Pasteur Limited (real clinical drug)
Tripacel Hybrid suspension for injection Sanofi Pasteur Limited (real clinical drug)
DTwP-HB Tritanrix GSK
Men-B Trumenba Pfiz
Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug)
Twinrix 720 ELISA units HAV and 20 micrograms HBV per milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug)
VAQTA 25 units per 0.5 milliliter suspension for injection Merck Canada Inc. (real clinical drug)
VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug)
Var VARILRIX GSK
VARIVAX III 1350 plaque forming units powder and diluent for solution for injection Merck Canada Inc. (real clinical drug)
COVID-19 VAXZEVRIA AZC
Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug)
ViVAXIM 160 antigen units and 25 micrograms suspension for injection Sanofi Pasteur Limited (real clinical drug)
Vivotif 10 billion units enteric coated capsule Crucell Switzerland LTD (real clinical drug)
Typh-O Vivotif Pax
Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug)
YF-VAX 109648 plaque forming units per 0.5 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug)
ZIFIVAX COVID-19 recombinant spike protein vaccine (real medicinal product)
Zos ZOSTAVAX MC
ZOSTAVAX II 19400 plaque forming units per 0.65 milliliter powder and diluent for suspension for injection Merck Canada Inc. (real clinical drug)

Start Page 2 of 2


Reference Sets

Canada English language reference set (foundation metadata concept)

Reference set descriptor

Description inactivation indicator reference set

GB English

US English

Back to Start